Linda has built a culture of excellence that permeates our organization,” says Cami Gearhart, JD, Quorum Review’s CEO. “She has built a regulatory team that provides world-class support of our board members, our researchers and our employees.
Seattle, WA (PRWEB) April 09, 2012
Linda Coleman, JD, CIP, CHC, CHRC, Director of Regulatory Affairs, and General Counsel for Quorum Review IRB, is a finalist for the Puget Sound Business Journal’s prestigious 2012 Outstanding Corporate Counsel at a Small Company Award (fewer than 1000 employees).
Ms. Coleman joined Quorum Review in 2007 as the Director of Regulatory Affairs. Today she provides a wealth of legal expertise as Director of the regulatory team, in addition to the role of General Counsel, which she assumed early in 2011. “Linda has built a culture of excellence that permeates our organization,” says Cami Gearhart, JD, Quorum Review’s CEO. “She has built a regulatory team that provides world-class support of our board members, our researchers and our employees.”
Ms. Coleman is not only a leader at Quorum, but also within her community. As President and Founder of the Education Access Network, Ms. Coleman prepares 150+ youth every year for success in higher education by providing free or low-cost access to preparatory courses or programs. Additionally, Ms. Coleman volunteers as Editor for Seattle University’s Law Journal and Editor-in-Chief for the WA Health Law Manual for the WA State Society of Healthcare Attorneys. Finally, Linda serves in leadership roles within a multitude of legal organizations and associations (Industry Pharmacogenomics Working Group, VA Puget Sound Health Care System and Washington State Society of Healthcare Attorneys).
The Puget Sound Business Journal's Corporate Counsel of the Year awards program highlights outstanding work by the state’s top in-house counsel. Finalists were nominated by community members and colleagues. Winners will be announced at the awards dinner on April 12th and published in the April 13th issue of the PSBJ.
About Quorum Review
Quorum Review is an independent ethics review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services and support includes 13 Board meetings each week plus expedited review, 24 hour site review turnaround, 36 hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s full service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.